Study: Many non-oncologic surrogate markers lack meta-analyses linking them to outcomes
Regulatory NewsJeff Craven
Biologics/ biosimilars/ vaccinesClinical TrialsExpedited pathwaysPharmaceuticalsSubmission and registrationUnited StatesRegulatory NewsJeff CravenBiologics/ biosimilars/ vaccinesClinical TrialsExpedited pathwaysPharmaceuticalsSubmission and registrationUnited States